Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Neoplasms 20 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 8 Neoplasm Metastasis 7 Lymphoma 7 Lung Neoplasms 7 Hematologic Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leukemia 5 Fatigue 5 Stomach Neoplasms 4 Depression 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pain 3 Myelodysplastic Syndromes 3 Motor Activity 3 Melanoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Analgesics, Opioid 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Palliative Care × Clear all

NCT06555588 2026-03-16

Engage

Duke University

Phase NA Recruiting

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡